Answers are grounded in this paper and cite their sources.
Case findings reveal anti-NMDAR encephalitis in a malaria survivor, suggesting a need for awareness and testing.
Background Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is the most common form of autoimmune encephalitis (AIE), often triggered by viral infections or tumors. This report describes a rare case following a parasitic infection. Case findings We report a rare case of anti-NMDAR encephalitis developing in a 40-year-old man following recovery from Plasmodium falciparum malaria. Despite confirmed parasite clearance, he presented eleven days later with seizures, altered consciousness, and acute psychosis. Anti-NMDAR antibodies were detected in the cerebrospinal fluid (CSF) via both immunofluorescence and cell-based assay, with no evidence of concurrent infection or malignancy. The patient showed rapid clinical improvement after first-line immunotherapy. Conclusion This report represents the first antibody-confirmed case of anti-NMDAR encephalitis following Plasmodium falciparum infection, highlighting malaria as a novel post-infectious trigger and expanding the recognized spectrum of post-malarial neurological syndromes (PMNS). It underscores that clinicians in endemic regions should maintain a high index of suspicion for AIE in patients with new neuropsychiatric symptoms after malaria and pursue early antibody testing and immunotherapy.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: